Ticker Report StockNews.com initiated coverage on shares of NeuroMetrix (NASDAQ:NURO - Free Report) in a report issued on Monday morning. The brokerage issued a sell rating on the medical device company's stock...\n more…
Ticker Report StockNews.com began coverage on shares of NeuroMetrix (NASDAQ:NURO - Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the medical device company's...\n more…
Ticker Report Research analysts at StockNews.com assumed coverage on shares of NeuroMetrix (NASDAQ:NURO - Get Free Report) in a note issued to investors on Saturday. The brokerage set a "sell" rating on the...\n more…
Globe Newswire WOBURN, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today for the purpose of clarity, reiterated that the Company is engaged in a review of strategic alternatives. In...\n more…
Ticker Report StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO - Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a "sell" rating on the medical...\n more…